Uranium Royalty (NASDAQ:UROY – Free Report) had its price objective increased by National Bank Financial from $3.75 to $4.00 in a report issued on Monday morning,BayStreet reports. They currently have an outperform rating on the stock.
Several other research firms have also recently issued reports on UROY. HC Wainwright reiterated a “buy” rating and set a $4.50 target price on shares of Uranium Royalty in a research report on Monday. Weiss Ratings raised Uranium Royalty from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Finally, Zacks Research cut Uranium Royalty from a “strong-buy” rating to a “hold” rating in a report on Monday, September 14th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $4.25.
View Our Latest Stock Report on UROY
Uranium Royalty Trading Down 1.7%
NASDAQ UROY opened at $3.42 on Monday. The stock has a market capitalization of $1.29 billion, a P/E ratio of 38.00 and a beta of 1.57. Uranium Royalty has a 52-week low of $2.56 and a 52-week high of $5.52. The firm has a 50-day moving average price of $4.17 and a 200 day moving average price of $3.64. The company has a quick ratio of 0.87, a current ratio of 0.88 and a debt-to-equity ratio of 0.49.
Uranium Royalty (NASDAQ:UROY – Get Free Report) last announced its quarterly earnings data on Monday, September 14th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.05. Uranium Royalty had a net margin of 25.88% and a return on equity of 10.86%. The firm had revenue of $51.68 million during the quarter, compared to the consensus estimate of $52.23 million. Equities research analysts expect that Uranium Royalty will post 0.14 EPS for the current year.
Hedge Funds Weigh In On Uranium Royalty
Large investors have recently made changes to their positions in the stock. Banque Cantonale Vaudoise increased its holdings in shares of Uranium Royalty by 9.7% in the 1st quarter. Banque Cantonale Vaudoise now owns 272,026 shares of the company’s stock valued at $994,000 after purchasing an additional 24,000 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of Uranium Royalty by 206.5% in the first quarter. Renaissance Technologies LLC now owns 196,751 shares of the company’s stock valued at $718,000 after purchasing an additional 132,551 shares during the period. Quantbot Technologies LP acquired a new stake in shares of Uranium Royalty in the second quarter valued at about $421,000. The Manufacturers Life Insurance Company boosted its holdings in Uranium Royalty by 189.0% during the first quarter. The Manufacturers Life Insurance Company now owns 149,821 shares of the company’s stock worth $547,000 after buying an additional 97,977 shares in the last quarter. Finally, Royal Bank of Canada boosted its holdings in Uranium Royalty by 10.3% during the first quarter. Royal Bank of Canada now owns 146,282 shares of the company’s stock worth $534,000 after buying an additional 13,692 shares in the last quarter. Hedge funds and other institutional investors own 24.19% of the company’s stock.
Uranium Royalty Company Profile
Uranium Royalty Corp. (NASDAQ: UROY) is a uranium-focused royalty and streaming company. It provides investors with exposure to the uranium sector through a portfolio of uranium interests rather than operating a traditional mining business. The company’s activities include acquiring uranium royalties, streams, offtake agreements, physical uranium, and equity interests in uranium exploration and development companies.
Uranium Royalty’s portfolio is linked to projects and properties in established uranium-producing and exploration regions, including the United States, Canada, Australia, and Paraguay.
Further Reading
- Five stocks we like better than Uranium Royalty
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Uranium Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uranium Royalty and related companies with MarketBeat.com's FREE daily email newsletter.
